Tag: Iovance Biotherapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Iovance Biotherapeutics Inc.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Expected to Post Earnings of -$0.52 Per Share

Added to Collection on: 2021-07-04 01:08:23

Tags for this article:

Finance
Money
Economy
Financial ratios
Valuation
Fundamental analysis
Corporate finance
Price?earnings ratio
ANGI Homeservices
Securities research
Earnings per share
Financial analyst
Iovance Biotherapeutics Inc.
Iovance Biotherapeutics

Click the tags to see associated articles and topics

View Article Details
Brokerages Expect Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Will Post Earnings of -$0.52 Per ...

Added to Collection on: 2021-07-24 13:18:45

Tags for this article:

Finance
Money
Economy
IAC
Stock market
Valuation
Price?earnings ratio
ANGI Homeservices
Securities research
Stock
Angi
Short
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Himension Fund Buys Roblox Corp, Shopify Inc, DoorDash Inc, Sells Peloton Interactive Inc, KE ...

Added to Collection on: 2021-08-03 11:37:30

Tags for this article:

Finance
Money
Financial economics
Corporate finance
Stock
Stock market
Investment funds
Mutual funds
Beyond Meat Inc.
Intellia Therapeutics Inc
KE Holdings Inc
Roblox Corp.
DoorDash Inc.
Peloton Interactive Inc.
Teladoc Health Inc.
Iovance Biotherapeutics Inc.
Li Auto Inc.
Himension Fund
Shopify Inc.

Click the tags to see associated articles and topics

View Article Details
Iovance Biotherapeutics, Inc. Expected to Post FY2025 Earnings of $7.62 Per Share (NASDAQ:IOVA)

Added to Collection on: 2021-08-10 11:56:07

Tags for this article:

Finance
Financial markets
Financial economics
Stock market
Corporate finance
Stock
Short
Citigroup
Iovance Biotherapeutics Inc.
Iovance Biotherapeutics

Click the tags to see associated articles and topics

View Article Details
Iovance Biotherapeutics Target of Unusually Large Options Trading (NASDAQ:IOVA) | MarketBeat

Added to Collection on: 2021-08-24 09:56:15

Tags for this article:

Finance
Money
Economy
Mitsui
Sumitomo Group
Sumitomo Mitsui Banking Corporation
Sumitomo Mitsui Financial Group
Short
Securities research
Stock
Financial analyst
Iovance Biotherapeutics Inc.
Iovance Biotherapeutics

Click the tags to see associated articles and topics

View Article Details
Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating

Added to Collection on: 2022-10-10 11:46:10

Tags for this article:

Medicine
Medical specialties
Clinical medicine
RTT
Cancer
Immune system
Treatment of cancer
Tumor-infiltrating lymphocytes
Melanoma
Programmed cell death protein 1
Cancer immunotherapy
Gene therapy
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Strs Ohio Acquires New Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Added to Collection on: 2022-10-22 08:44:26

Tags for this article:

Financial markets
Economy
Financial economics
Financial regulation
Short
Stock
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Advisors Asset Management Inc. Sells 9883 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Added to Collection on: 2022-11-19 23:19:50

Tags for this article:

Financial markets
Finance
Financial economics
Financial regulation
Short
Stock
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Sold by Principal Financial Group Inc.

Added to Collection on: 2023-11-19 17:03:41

Tags for this article:

Equity securities
Stock market
Corporate finance
Financial capital
Private equity
Stock
Price?earnings ratio
NASDAQ
PRINCIPAL FINANCIAL GROUP INC.
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
FDA approves first cell therapy to treat aggressive forms of melanoma - NPR

Added to Collection on: 2024-02-17 17:23:30

Tags for this article:

Cancer immunotherapy
Cancer
Melanoma
Skin cancer
Immunotherapy
CAR T cell
Cancer treatment
Pembrolizumab
Iovance Biotherapeutics Inc.

Click the tags to see associated articles and topics

View Article Details